Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01641068 : Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms
PhaseN/A
AgesMin: 21 Years Max: 90 Years
Eligibility
Inclusion Criteria:

- Subjective concern about declines in cognitive functioning related to a diagnosis of
cancer and/or cancer related treatment

- Prior treatment of gynecologic or breast cancer with chemotherapy

- Completion of treatment (e.g., chemotherapy, radiation therapy, surgery, etc.) for
gynecologic or breast cancer 6 months or greater in the past

- Able to comprehend and speak English

- For the subset of participants who will undergo magnetic resonance imaging (MRI),
ability to withstand lying down in small area (MRI scanner) for 50 minutes

- Completion of successful fMRI safety screening

- Able to give informed consent

- Able to undergo informed consent procedures and 3 hours of testing, plus 8 1-hour
cognitive rehabilitation sessions with breaks

Exclusion Criteria:

- Ongoing treatment for ovarian or other cancer (e.g., chemotherapy, radiation,
surgery, etc.)

- Cancer onset before the age of 21

- Unstable medical problems (such as unstable heart disease, unstable hypertension,
diabetes in poor control, respiratory disease complicated by hypoxia or hypercapnia,
infectious illnesses, unstable thyroid dysfunction, currently hospitalized)

- History of, or current symptoms of, serious psychiatric disorder requiring
antipsychotic medications or hospitalization; mild depression or stable
anti-depressants, and anti-seizure medications are acceptable; anti-anxiety
medications may be acceptable

- Current alcohol over-use as defined by currently consuming 4 drinks or more per day
or binge drinking (6 or more drinks in one night) within the past week

- History of or current neurological illness that significantly impacts cognition (e.g.
stroke, multiple sclerosis, Parkinson's disease, Alzheimer's disease, head injury,
epilepsy, etc)

- History of brain injury that significantly impacted cognition; as indicated responses
on the Ohio State University Traumatic Brain Injury Identification Method (OSU
TBI-ID) greater or equal to any of the following: 30 minutes or more of loss of
consciousness (LOC), two or more mild cases within two weeks of each other, or any
injury with loss of consciousness before the age of 15

- History of central nervous system (CNS) tumor

- A score of 25 or more on the Patient Health Questionnaire (PHQ-9) on the first visit

- A score of 26 or below on the Mini Mental Status Exam (MMSE) triggers a review by an
investigational team before enrolling

- A score above 45 on the Wender Utah Rating Scale for attention deficit disorder (ADD)
(WURS)

- For the subset of participants undergoing neuroimaging:

- Medical history or devices which make an MRI unsafe or uncomfortable (e.g.,
magnetic rods or pins, metal plates or screws, pacemaker)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01641068      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740